Neurotropin - Argenes/Nippon ZokiAlternative Names: Fibromylagia therapy - Argenes/Nippon Zoki; Neurotropin
Latest Information Update: 16 Nov 2006
At a glance
- Originator Nippon Zoki
- Class Non-opioid analgesics; Polysaccharides
- Mechanism of Action Alpha 2 adrenergic receptor agonists; Serotonin 3 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Neuropathic pain